Nevro Revenue Growth Rates (NVRO), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Nevro Corp   (NYSE: NVRO)
 

NVRO's Revenue Growth by Quarter and Year

Nevro 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NVRO Revenue (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
4th Quarter December 105.92
3rd Quarter September 96.61
2nd Quarter June 103.47
1st Quarter March 101.53
FY 407.53

NVROs Annual Revenue
Nevro 's Revenue in the fiscal year 2024 $ 407.53 millions
Nevro 's Revenue in the fiscal year 2023 $ 425.06 millions
Nevro 's Revenue in the fiscal year 2022 $ 406.37 millions
Nevro 's Revenue in the fiscal year 2021 $ 386.91 millions
Nevro 's Revenue in the fiscal year 2020 $ 362.05 millions




NVRO Revenue fourth quarter 2024 Y/Y Growth Comment
Nevro Corp reported decrease in Revenue in the fourth quarter 2024 by -9.01% to $ 105.92 millions, from the same quarter in 2023.
The decrease in the fourth quarter 2024 Nevro Corp 's Revenue compares unfavorably to the Company's average Revenue jump of 45.63%.

Looking into fourth quarter 2024 results within Medical Equipment & Supplies industry 155 other companies have achieved higher Revenue growth. While Nevro Corp ' s Revenue decline of -9.01% ranks overall at the positon no. 3451 in the fourth quarter 2024.


NVRO Revenue ( Y/Y Growth %) 2024
 2023 2022 2021
4th Quarter December -9.01 % 2.26 % 10.78 % -6.35 %
3rd Quarter September -6.68 % 3.04 % 7.79 % -14.06 %
2nd Quarter June -4.91 % 4.41 % 1.84 % 81.47 %
1st Quarter March 5.4 % 9.67 % -0.87 % 1.3 %
FY   -4.13 % 4.6 % 5.03 % -

Financial Statements
Nevro 's fourth quarter 2024 Revenue $ 105.92 millions NVRO's Income Statement
Nevro 's fourth quarter 2023 Revenue $ 116.41 millions Quarterly NVRO's Income Statement


NVRO Revenue (Quarter on Quarter Growth %)

 2024
 2023 2022 2021
4th Quarter December 9.64 % 12.45 % 13.31 % 10.25 %
3rd Quarter September -6.63 % -4.86 % -3.59 % -8.91 %
2nd Quarter June 1.91 % 12.96 % 18.64 % 15.48 %
1st Quarter March -12.78 % -15.38 % -14.52 % -19.25 %
FY (Year on Year)   -4.13 % 4.6 % 5.03 % -


Back to NVRO Growth rate Comparisons >> Back to NVRO Growth rate Comparisons >>


Revenue fourth quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #156
Healthcare Sector #481
Overall #3451

Revenue Y/Y Growth Statistics
High Average Low
385.2 % 45.63 % -39.74 %
(Dec 31 2016)   (Mar 31 2021)
Revenue fourth quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #156
Healthcare Sector #481
Overall #3451
Revenue Y/Y Growth Statistics
High Average Low
385.2 % 45.63 % -39.74 %
(Dec 31 2016)   (Mar 31 2021)

Revenue by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Nevro 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
115.06 % 9.08 % -35.53 %
(Dec 31 2015)  


NVRO's IV. Quarter Q/Q Revenue Comment
Nevro Corp achieved in the IV. Quarter 2024 above company average sequential Revenue increase of 9.64%, to $ 105.92 millions, from $96.61 millions in the third quarter.

Within Medical Equipment & Supplies industry 81 other companies have achieved higher Revenue quarter on quarter growth. While Nevro 's Revenue growth quarter on quarter, overall rank is 1090.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #82
Healthcare Sector #250
Overall #1090
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #82
Healthcare Sector #250
Overall #1090
Revenue Q/Q Growth Statistics
High Average Low
115.06 % 9.08 % -35.53 %
(Dec 31 2015)  


NVRO's IV. Quarter Q/Q Revenue Comment
Nevro Corp achieved in the IV. Quarter 2024 above company average sequential Revenue increase of 9.64%, to $ 105.92 millions, from $96.61 millions in the third quarter.

Within Medical Equipment & Supplies industry 81 other companies have achieved higher Revenue quarter on quarter growth. While Nevro 's Revenue growth quarter on quarter, overall rank is 1090.


Nevro 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2024)		 12 Months Ending
(Sep 30 2024)		 12 Months Ending
(Jun 30 2024)		 12 Months Ending
(Mar 31 2024)		 12 Months Ending
(Dec 31 2023)
Cumulative Revenue 12 Months Ending $ 407.53 $ 418.02 $ 424.92 $ 430.26 $ 425.06
Y / Y Revenue Growth (TTM) -4.12 % -1.06 % 1.3 % 3.71 % 4.6 %
Year on Year Revenue Growth Overall Ranking # 1077 # 1095 # 1123 # 0 # 0
Seqeuential Revenue Change (TTM) -2.51 % -1.62 % -1.24 % 1.22 % 0.61 %
Seq. Revenue Growth (TTM) Overall Ranking # 2189 # 1607 # 1683 # 0 # 0


Cumulative Revenue growth Comment
Nevro 's cumulative 12 months Revenue continue to decrease, but on the faster rate at -4.12% year on year, at Dec 31 2024 compare to the -1.06% decrease at Sep 30 2024. If the Nevro 's fiscal year would end at Dec 31 2024, annual Revenue would be $408 millions.

In the Healthcare sector 172 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 1077, from total ranking in previous quarter at 1095.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 115
Healthcare Sector # 173
Overall # 1077

Revenue TTM Y/Y Growth Statistics
High Average Low
228.28 %
 22.37 %
-8.19 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 115
Sector # 334
S&P 500 # 2189
Cumulative Revenue growth Comment
Nevro 's cumulative 12 months Revenue continue to decrease, but on the faster rate at -4.12% year on year, at Dec 31 2024 compare to the -1.06% decrease at Sep 30 2024. If the Nevro 's fiscal year would end at Dec 31 2024, annual Revenue would be $408 millions.

In the Healthcare sector 172 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 1077, from total ranking in previous quarter at 1095.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 115
Healthcare Sector # 173
Overall # 1077

Revenue TTM Y/Y Growth Statistics
High Average Low
228.28 %
22.37 %
-8.19 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 115
Sector # 334
S&P 500 # 2189




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
NVRO's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue decrease for the quarter ending Dec 31 2024 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2024
Adapthealth Corp -0.19%$ -0.185 millions
Bioaffinity Technologies Inc -0.26%$ -0.260 millions
Organon and Co -0.38%$ -0.375 millions
Royalty Pharma Plc-0.41%$ -0.407 millions
Carlisle Companies Incorporated-0.41%$ -0.408 millions
Silo Pharma Inc-0.41%$ -0.409 millions
Shl Telemedicine Ltd-0.52%$ -0.519 millions
Cytek Biosciences Inc -0.59%$ -0.586 millions
Kronos Bio Inc -0.70%$ -0.700 millions
Koninklijke Philips Nv-0.81%$ -0.815 millions
Enhabit Inc -0.92%$ -0.921 millions
Charles River Laboratories International inc -1.08%$ -1.078 millions
Elanco Animal Health Incorporated-1.45%$ -1.449 millions
Illumina Inc -1.60%$ -1.604 millions
Perrigo Company Plc-1.62%$ -1.616 millions
Fonar Corporation-1.72%$ -1.717 millions
Quipt Home Medical Corp -1.90%$ -1.905 millions
Bio rad Laboratories Inc -1.91%$ -1.910 millions
Surmodics Inc -2.06%$ -2.062 millions
Avantor Inc -2.10%$ -2.101 millions
Petvivo Holdings Inc -2.11%$ -2.111 millions
Iridex Corp-2.15%$ -2.153 millions
Assertio Holdings inc -2.43%$ -2.431 millions
Apyx Medical Corp-2.58%$ -2.578 millions
Bioxcel Therapeutics Inc -2.66%$ -2.660 millions
Zynex inc -2.66%$ -2.665 millions
Nrc Health-2.88%$ -2.879 millions
Teladoc Health Inc -3.03%$ -3.033 millions
Orchestra Biomed Holdings Inc -3.44%$ -3.435 millions
Xenetic Biosciences Inc -3.45%$ -3.449 millions


About Nevro Revenue Growth Rates (NVRO), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Nevro Corp (CIK 1444380).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001444380-25-000024
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Nevro Corp’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.